Should buy antisoma shares

Should buy antisoma shares

Posted: Antic Date of post: 20.06.2017

Binary options - start trading binary options today. Trade and make a profit from binary options using Binomo broker.

To see a tutorial on how the Follow Feed works: To dive right in and see the Follow Feed in action with your first follow: You can see your current Follow list as a Monitor list here.

Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Free BB PBB. Canada AMEX Asm International EU Avino Silver And Gold Mines Ltd TSXV Asmgroup WSE. You've just added your first Follow!

Antisoma shares plunge after latest cancer drug setback | The Independent

This is a brand new feature that will be the core of several new tools we're building for you. View Tutorial To dive right in and see the Follow Feed in action with your first follow: Follow Feed You can see your current Follow list as a Monitor list here.

Antisoma Share Chat ASM. Share Name Share Symbol Market Type Share ISIN Share Description Antisoma LSE: ASM London Ordinary Share GB ORD 1P. Comment on ASM Post. Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously. Register now to create your own custom streaming stock watchlist. Bad Login - try again. Don't have an account?

Unlikely considering its changing purpose to an investment company! Read Full Thread Reply.

Antisoma Shares Plunge 55% As Cancer Drug Fails in Trials - WSJ

What a sorry state of affairs. Antisoma tried real hard to crack the cancer blight, real pity it failed. At least they really had a good go at it. OXB 5p to 50p same,wife of ceo sold her total holding at 54p after that I never went back in.

There is a huge failure list but I did believe in the possible good outcome of quite a few of these research stocks, as like so many of us we have lost loved ones to this terrible disease We live in hope. ASM might just develop a game changer yet.

Antisoma PLC is proposing to change its name to Sarossa Capital PLC. I held these a few years back, got out at a loss, somewhat higher than this!

Do keep up Watson! Another small cap pharma biotech in trouble Only 1 in 10 make it to profitability picking the ones that do or might ain't easy Taken me 5 years. Not the Antisoma we once knew, gamboling by George! Mind you there algorithmic trading system money in gamboling!

GVC has offered as consideration, for the businesses of Sportingbet which it proposes to acquire and forex rate of iraqi dinar, Sportingbet shareholders are also being forex bloomberg should buy antisoma shares financed through a payment by William Hill in relation to the businesses of Sportingbet fx options trading handbook be should buy antisoma shares to William Hill.

As part of the GVC shares consideration, Sportingbet shareholders are being offered the opportunity to accept either these new GVC ordinary shares or a cash alternative of To the extent that a mix and match arrangement does not operate so as to deliver to any eligible Sportingbet shareholders the full amount of cash consideration for which they have elected, GVC has entered into a series of agreements whereby various parties have agreed to subscribe new GVC ordinary shares to underpin the cash consideration elected for by Sportingbet shareholders.

Antisoma has entered into such an agreement with GVC to subscribe up to 1, new GVC ordinary shares at As consideration for this commitment, Antisoma has been granted subscription options over a furthernew GVC ordinary shares, which are exercisable at Antisoma's commitment continues until the earlier of the date on which the Offer is declared wholly unconditional or 30 June Antisoma will make a further announcement as soon as possible thereafter as to the number of new GVC ordinary shares subscribed under this agreement.

In the 6 months ended 30 JuneGVC made a profit before taxation of Euro 5. Its net assets at 30 June amounted to Euro Further information on the Offer, GVC and Sportingbet is set out in the announcement of the Offer of today's date. Another month passes with no news at all. Great work if you can get it.

Antisoma Buying Xanthus Pharma - PE Hub

I would be happy if they used all of the cash to buy shares in Scancell Holdings. I think it is a not unreasonable expectation from shareholders that such management that remain and draw salaries from company funds could issue some sort of news statement, or turn the company into a closed tracker fund or better still wind the company up and return what little remains to shareholders.

Spending money on directors remuneration. Anybody know what on earth Antisoma are doing now? There are convincing arguments that when a company clearly has failed but still has some assets to wind it up and return whatever value there is left to shareholders. Or if that is too complex and majority shraeholders are desperate to keep it trading perhaps ASM should reinvent itself as a tracker fund - more profitable probably johnsmith than the 'range of smaller investments' you envisage.

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil. ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico. ADVFN France ADVFN US Finance Manila.

Rating 4,2 stars - 854 reviews
inserted by FC2 system